Silvant Capital Management LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
Silvant Capital Management LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,919,882
+5.9%
15,8380.0%0.12%
+13.7%
Q2 2023$1,813,768
-45.0%
15,838
-33.8%
0.10%
-52.6%
Q1 2023$3,298,823
+39.0%
23,934
+30.7%
0.22%
+28.0%
Q4 2022$2,373,646
+433.4%
18,318
+354.8%
0.17%
+460.0%
Q3 2022$445,000
+47.4%
4,0280.0%0.03%
-58.9%
Q2 2022$302,000
-4.1%
4,0280.0%0.07%
+21.7%
Q1 2022$315,000
-13.2%
4,0280.0%0.06%
-3.2%
Q4 2021$363,000
-8.3%
4,028
-6.0%
0.06%
-12.7%
Q3 2021$396,000
+18.9%
4,2870.0%0.07%
+36.5%
Q2 2021$333,000
+4.1%
4,2870.0%0.05%
-5.5%
Q1 2021$320,000
-57.3%
4,287
-2.4%
0.06%
-57.0%
Q4 2020$749,000
+21.4%
4,3930.0%0.13%
+11.3%
Q3 2020$617,000
-12.4%
4,3930.0%0.12%
-9.4%
Q2 2020$704,000
+63.7%
4,3930.0%0.13%
+35.1%
Q1 2020$430,000
-24.2%
4,3930.0%0.09%
-8.7%
Q4 2019$567,000
+71.3%
4,3930.0%0.10%
+58.5%
Q3 2019$331,000
-50.4%
4,3930.0%0.06%
-45.8%
Q2 2019$668,000
+27.5%
4,3930.0%0.12%
+27.7%
Q1 2019$524,000
+9.4%
4,3930.0%0.09%
-2.1%
Q4 2018$479,000
-32.5%
4,3930.0%0.10%
+9.1%
Q3 2018$710,000
+22.2%
4,3930.0%0.09%
+22.2%
Q2 2018$581,000
+50.9%
4,393
-15.5%
0.07%
+46.9%
Q1 2018$385,0005,2000.05%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Evolutionary Tree Capital Management, LLC 68,937$5,138,0003.04%
Avoro Capital Advisors LLC 2,150,000$160,240,0002.77%
Casdin Capital, LLC 550,000$40,992,0001.22%
TOBAM 371,107$27,659,0001.18%
Ikarian Capital, LLC 455,900$33,978,0001.14%
Eventide Asset Management 697,156$51,959,0000.77%
FOX RUN MANAGEMENT, L.L.C. 4,902$365,0000.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 31,500$2,348,0000.62%
Sivik Global Healthcare LLC 20,000$1,491,0000.54%
Rock Springs Capital Management LP 328,750$24,502,0000.54%
View complete list of SAREPTA THERAPEUTICS INC shareholders